Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI: A multicenter, randomized, double‐blind, parallel‐controlled clinical trial

氨氯地平 医学 高同型半胱氨酸血症 血压 内科学 同型半胱氨酸 随机对照试验 冲程(发动机) 优势比 胃肠病学 机械工程 工程类
作者
Huihui Bao,Xiao Huang,Ping Li,Chang‐Sheng Sheng,Jin Zhang,Zhirong Wang,Demin Song,Lihua Hu,Congcong Ding,Zaihua Cheng,Chen Yao,Guangliang Chen,Yimin Cui,Xianhui Qin,Genfu Tang,Xiaobin Wang,Yong Huo,Xiaoshu Cheng,Ji-Guang Wang
出处
期刊:Journal of Clinical Hypertension [Wiley]
卷期号:25 (8): 689-699 被引量:5
标识
DOI:10.1111/jch.14697
摘要

Hyperhomocysteinemia with hypertension can synergistically increase the risk of stroke. The China stroke primary prevention trial showed that combining 0.8 mg folic acid (FA) with angiotensin-converting enzyme inhibitor (ACEI) can effectively lower plasma total homocysteine (tHcy) and blood pressure (BP); and reduce first stroke risk by additional 21% compared to ACEI alone. However, intolerance to ACEI is common in Asians and amlodipine can be alternative. This is a multicenter, randomized, double-blind, parallel-controlled clinical trial (RCT) which evaluated whether amlodipine combined with FA is more efficacious than amlodipine alone in lowering tHcy and BP among Chinese hypertensive with hyperhomocysteinemia and intolerance to ACEI. 351 Eligible patients were randomly assigned by 1:1:1 ratio to receive amlodipine-FA tablet daily (amlodipine 5 mg/FA 0.4 mg, A group); amlodipine 5 mg/FA 0.8 mg tablet daily (B group); amlodipine 5 mg daily (C group, control group). Follow-up was conducted at 2, 4, 6, and 8 weeks. The primary outcome was efficacy of lowering both tHcy and BP at the end of 8-week treatment. Compared with C group, A group had a significantly higher rate of lowering both tHcy and BP (23.3% vs. 6.0%; Odds Ratio [OR], 8.68; 95% CI, 3.04-24.78, P < .001); B group also had a higher rate of lowering both tHcy and BP (20.3% vs. 6.0%; OR: 5.90; 95% CI, 2.11-16.47, P < .001). This RCT showed amlodipine combined with FA compared with amlodipine alone, each had significantly higher efficacy of lowering both tHcy and BP. No difference was found in BP-lowering and occurrence of adverse events between the three groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一直向前发布了新的文献求助10
刚刚
明芬完成签到,获得积分10
3秒前
4秒前
123456完成签到,获得积分10
7秒前
结实的慕凝完成签到,获得积分10
9秒前
苗条小土豆完成签到,获得积分10
9秒前
flance完成签到 ,获得积分10
11秒前
12秒前
fanfan完成签到 ,获得积分10
14秒前
SkyTsai完成签到,获得积分10
14秒前
17秒前
18秒前
轻松的惜芹应助诚心谷南采纳,获得10
18秒前
天天快乐应助sml采纳,获得10
19秒前
21秒前
22秒前
22秒前
华仔应助sxx采纳,获得10
25秒前
YJ888发布了新的文献求助10
26秒前
27秒前
哼哼唧唧发布了新的文献求助10
27秒前
石大大发布了新的文献求助10
29秒前
huoguo完成签到,获得积分10
30秒前
小二郎应助完美芒果采纳,获得10
30秒前
Liufgui应助紫竹魔笛采纳,获得10
32秒前
33秒前
35秒前
Liufgui应助YJ888采纳,获得10
36秒前
赘婿应助麦子采纳,获得10
36秒前
37秒前
KK发布了新的文献求助10
37秒前
娟姐完成签到,获得积分10
38秒前
ding应助李朝富采纳,获得10
39秒前
桐桐应助学术蝗虫采纳,获得10
40秒前
杨桃发布了新的文献求助10
40秒前
41秒前
biubiudididi发布了新的文献求助10
41秒前
YUMI发布了新的文献求助10
42秒前
科研通AI5应助slx采纳,获得10
42秒前
搜集达人应助娟姐采纳,获得10
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176